Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Multi Cap Growth Alphadex First Trust | FAD | Apr 17, 2025 | 123.56 | +0.38 |
Multi Cap Value Alphadex First Trust | FAB | Apr 17, 2025 | 73.17 | +1.37 |
Multi Ways Holdings Limited | MWG | Apr 17, 2025 | 0.31 | +6.96 |
MultiSensor AI | MSAI | Apr 17, 2025 | 0.84 | +1.13 |
Mural Oncology | MURA | Apr 17, 2025 | 2.70 | +11.57 |
Murano Global Investments | MRNO | Apr 17, 2025 | 9.10 | 0.00 |
Murphy Oil | MUR | Apr 17, 2025 | 21.37 | +3.79 |
Murphy USA | MUSA | Apr 17, 2025 | 510.54 | +0.81 |
Mustang Bio | MBIO | Apr 17, 2025 | 1.33 | -0.75 |
MV Oil Royalty Trust | MVO | Apr 17, 2025 | 5.98 | +2.40 |
MVB Financial | MVBF | Apr 17, 2025 | 15.84 | +0.76 |
My Size | MYSZ | Apr 17, 2025 | 1.48 | +7.25 |
Myers Industries | MYE | Apr 17, 2025 | 9.46 | +0.96 |
Mynd.Ai | MYND | Apr 17, 2025 | 0.67 | -1.80 |
Myomo | MYO | Apr 17, 2025 | 4.37 | +2.34 |
MYR Group | MYRG | Apr 17, 2025 | 114.70 | +0.69 |
Myriad Genetics | MYGN | Apr 17, 2025 | 7.64 | -3.41 |
MYT Netherlands Parent ADR | MYTE | Apr 17, 2025 | 7.70 | -1.41 |
N-able | NABL | Apr 17, 2025 | 6.35 | -1.40 |
N2OFF | NITO | Apr 17, 2025 | 0.22 | +1.67 |
Naas Technology ADR | NAAS | Apr 17, 2025 | 0.46 | +1.68 |
Nabors Energy Transition II | NETDU | Apr 17, 2025 | 11.12 | -0.09 |
Nabors Energy Transition II | NETD | Apr 17, 2025 | 10.97 | -0.18 |
Nabors Industries | NBR | Apr 17, 2025 | 30.91 | +7.44 |
NACCO Industries | NC | Apr 17, 2025 | 36.85 | -2.36 |
Nano Dimension ADR | NNDM | Apr 17, 2025 | 1.51 | +2.72 |
Nano Labs | NA | Apr 17, 2025 | 4.30 | +1.75 |
Nano Nuclear Energy | NNE | Apr 17, 2025 | 19.86 | -3.22 |
Nano-X Imaging | NNOX | Apr 17, 2025 | 5.20 | +15.56 |
Nanobiotix ADR | NBTX | Apr 17, 2025 | 3.29 | +0.22 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.